Back
Results - Announcements
JHS Svendgaard Laboratories Ltd consolidated sales down 7.09% on year in Q2FY2026, net profit tanked by 130.53%
11-Aug-2026, 08:51
JHS Svendgaard Laboratories Ltd share price inched up 1.15% to Rs 7.95. The Company's net profit witnessed a sharp fall of 130.53% to Rs 1.09 crore, while revenue from operations eased by 7.09% to Rs 30.38 crore in Q2FY26 over Q1FY26. The market capitalization of Personal Care industry group stocks on BSE stood at Rs 3.57 lakh crore, climbing 14.21%. It has slipped by 0.66% over last one week and gained upto 1.30% in last one month while the market capitalization of JHS Svendgaard Laboratories Ltd has significantly gained 17.55% and 1.67% in the same period respectively. Profit before tax (PBT) of JHS Svendgaard Laboratories Ltd stood at Rs 0.06 crore in Q2 FY26, nosediving by 90.48% year-on-year, and tumbling by 102.01% quarter-on-quarter. EBITDA came in at Rs 2 crore, surging by 197.01% YoY and tanking 184.68% sequentially. Total expenses fell by 16.72% to Rs 30.13 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 18.73 crore, plunging by 23.58% YoY, while employee benefits expense was at Rs 2.87 crore, falling 7.72% YoY. For the TTM ended FY26, revenue from operations soared by 29.94% to Rs 92.0 crore, while net profit jumped 386.21% to Rs 19.74 crore, compared to previous TTM. EBITDA saw a sharp decline of 464% to Rs 6.89 crore, and PBT soared 264.72% to Rs 12.51 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.18 crore in FY26, as against Rs 9.18 crore in FY25. JHS Svendgaard Laboratories Ltd nosedived by 32.57% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.
JHS Svendgaard Laboratories Ltd share price inched up 1.15% to Rs 7.95. The Company's net profit witnessed a sharp fall of 130.53% to Rs 1.09 crore, while revenue from operations eased by 7.09% to Rs 30.38 crore in Q2FY26 over Q1FY26. The market capitalization of Personal Care industry group stocks on BSE stood at Rs 3.57 lakh crore, climbing 14.21%. It has slipped by 0.66% over last one week and gained upto 1.30% in last one month while the market capitalization of JHS Svendgaard Laboratories Ltd has significantly gained 17.55% and 1.67% in the same period respectively. Profit before tax (PBT) of JHS Svendgaard Laboratories Ltd stood at Rs 0.06 crore in Q2 FY26, nosediving by 90.48% year-on-year, and tumbling by 102.01% quarter-on-quarter. EBITDA came in at Rs 2 crore, surging by 197.01% YoY and tanking 184.68% sequentially. Total expenses fell by 16.72% to Rs 30.13 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 18.73 crore, plunging by 23.58% YoY, while employee benefits expense was at Rs 2.87 crore, falling 7.72% YoY. For the TTM ended FY26, revenue from operations soared by 29.94% to Rs 92.0 crore, while net profit jumped 386.21% to Rs 19.74 crore, compared to previous TTM. EBITDA saw a sharp decline of 464% to Rs 6.89 crore, and PBT soared 264.72% to Rs 12.51 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.18 crore in FY26, as against Rs 9.18 crore in FY25. JHS Svendgaard Laboratories Ltd nosedived by 32.57% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.